Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical results

Overview of attention for article published in Radiation Oncology, September 2016

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age and source (65th percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 2,366 followers.

Phase II trial of hypoFx VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical results https://t.co/jF42z21iL0

Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year… https://t.co/5rPT0QUiRn #breastcancer

Radiat Oncol: "Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year toxic… https://t.co/LNUd9q2o6H

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.